Additional Proxy Soliciting Materials (definitive) (defa14a)
May 13 2019 - 5:26PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE
SECURITIES EXCHANGE ACT OF 1934
Filed by the
Registrant ☒ Filed by a party other than the
Registrant ☐
Check the appropriate box:
|
|
|
|
|
☐
|
|
Preliminary Proxy Statement
|
|
|
|
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
|
|
☐
|
|
Definitive Proxy Statement
|
|
|
|
|
☒
|
|
Definitive Additional Materials
|
|
|
|
|
☐
|
|
Soliciting Material Pursuant to Section 240.14a-11(c) or Section 240.14a-12
|
FUSE MEDICAL, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
|
|
|
|
|
|
|
☒
|
|
No fee required.
|
|
|
|
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
|
|
(1)
|
|
Title of each class of securities to which transaction applies:
|
|
|
|
(2)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing
fee is calculated and state how it was determined):
|
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
(5)
|
|
Total fee paid:
|
|
|
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|
|
|
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.
|
|
|
|
|
|
|
Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
|
|
|
(1)
|
|
Amount Previously Paid:
|
|
|
|
(2)
|
|
Form, Schedule or Registration Statement:
|
|
|
|
(3)
|
|
Filing Party:
|
|
|
|
(4)
|
|
Date Filed:
|
Important Notice Regarding the Availability of Proxy Materials for the
Annual Shareholder Meeting To Be Held on June 26, 2019
This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you
to access and review all of the important information contained in the proxy materials before voting. To view the proxy statement and annual report, go to
www.proxydocs.com/FZMD
. To submit your proxy while visiting that site, you will need
the 12-digit control number in the shaded gray box below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Under United States Securities and Exchange
Commission rules, proxy materials do not have to be delivered in paper. Proxy materials may be distributed by making them available on the Internet. We have chosen to use these online procedures for our 2019 Annual Meeting and need YOUR
participation.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
If you want to receive a paper or e-mail copy of the proxy materials, you must request one. There is no
charge to you for requesting a copy. In order to receive a paper package in time for this year’s annual meeting, please make this request on or before June 14, 2019.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For a convenient way to
VIEW Proxy Materials and VOTE online
go to:
www.proxydocs.com/FZMD
|
|
|
Proxy Materials Available to View or Receive:
1. Proxy Statement 2. Annual Report on Form 10-K
Printed materials may be requested by one of the following methods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INTERNET
www.investorelections.com/FZMD
|
|
|
|
TELEPHONE
(866) 648-8133
|
|
|
|
*E-MAIL
paper@investorelections.com
|
|
|
|
|
|
You must use the 12-digit control
number
located in the shaded gray box below.
|
|
|
|
* If requesting material by e-mail, please send a blank e-mail with the 12-digit control
number in the shaded gray box in the subject line. No other requests, instructions or other inquiries should be included with your e-mail requesting material.
|
|
|
Fuse Medical, Inc. Notice of Annual Meeting
|
|
|
|
|
|
|
|
Date: Wednesday, June 26, 2019
Time: 4:00 P.M. (Central Daylight Time)
Place: Hyatt Regency North Dallas/Richardson
701 E. Campbell Road
Richardson, TX 75081
|
The purpose of the Annual Meeting is to take action on the following proposals:
The Board of Directors recommends that you vote “FOR” each of the nominees listed below:
|
1.
|
The election of five (5) directors to serve on the board of directors:
|
|
|
|
|
|
|
|
01 Renato V. Bosita, Jr., MD
02 Mark W. Brooks
03 Ricky Raj S. Kalra, MD
|
|
04 William E. McLaughlin, III
05 Christopher C. Reeg
|
The Board of Directors recommends that you vote “FOR” the following:
|
2.
|
The ratification of the appointment of Montgomery Coscia Greilich LLP as our independent registered public
accounting firm for the fiscal year ended December 31, 2018, and the fiscal year ending December 31, 2019.
|
|
3.
|
The ratification of the adoption of the amended and restated bylaws of Fuse Medical, Inc.
|
To transact such other business as may properly come before our Annual Meeting and any adjournment or
postponement thereof.
Fuse Medical (PK) (USOTC:FZMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Fuse Medical (PK) (USOTC:FZMD)
Historical Stock Chart
From Sep 2023 to Sep 2024
